Literature DB >> 3703290

Multiple sclerosis: magnetic resonance imaging, evoked responses, and spinal fluid electrophoresis.

M R Farlow, O N Markand, M K Edwards, J C Stevens, O J Kolar.   

Abstract

Magnetic resonance images (MRI), evoked responses (ER), and CSF findings were compared in 39 patients with possible, probable, or definite MS. MRI disclosed multiple lesions (72%) more often than ERs (55%) in the total group of patients. In possible MS, MRI showed multiple lesions in 71%, and ER abnormalities were found in 41%. MRI is the preferred test for patients with suspected MS, but ERs are useful when MRI is normal and in the evaluation of optic nerve or spinal cord lesions.

Entities:  

Mesh：

Year:  1986        PMID： 3703290     DOI： 10.1212/wnl.36.6.828

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  10 in total

1.  A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis.

Authors:  E Paolino; E Fainardi; P Ruppi; M R Tola; V Govoni; I Casetta; V C Monetti; E Granieri; M Carreras
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Role of saccadic analysis in the diagnosis of multiple sclerosis in the era of magnetic resonance imaging.

Authors:  G Tedeschi; S Allocca; A Di Costanzo; A Diano; V Bonavita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

3.  Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis.

Authors:  G Comi; V Martinelli; S Medaglini; T Locatelli; M Filippi; N Canal; F Triulzi; A Del Maschio
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

4.  MRI in the investigation of patients with myelopathy thought to be due to multiple sclerosis.

Authors:  A Papadopoulos; A Gouliamos; S Trakadas; A Kalovidouris; P Sgouropoulos; S Gatzonis; L Vlahos
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

5.  Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis.

Authors:  G Filippini; G C Comi; V Cosi; L Bevilacqua; M Ferrarini; V Martinelli; R Bergamaschi; M Filippi; A Citterio; L D'Incerti
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

6.  An attempt to quantify magnetic resonance imaging in multiple sclerosis--correlation with clinical parameters.

Authors:  L Kappos; D Städt; W Keil; M Ratzka; T Heitzer; S Schneiderbanger-Grygier
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

7.  Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; S Mammi; V Martinelli; T Locatelli; G Scotti; S Amadio; N Canal; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

8.  Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.

Authors:  F Alcindor; R Valderrama; M Canavaggio; H Lee; A Katz; C Montesinos; R E Madrid; R R Merino; P A Pipia
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  Magnetic resonance imaging in patients with multiple sclerosis and spinal cord involvement: 28 cases.

Authors:  P A Uldry; F Regli; A Uské
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

10.  Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.

Authors:  S Beer; K M Rösler; C W Hess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.